Denali Therapeutics Inc. DNLI Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Prepaid Expense and Other Assets at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s increase (decrease) in prepaid expense and other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s increase (decrease) in prepaid expense and other assets?
- Denali Therapeutics Inc. (DNLI) reported increase (decrease) in prepaid expense and other assets of $2.29M in Q1 2026.
- How has Denali Therapeutics Inc.'s increase (decrease) in prepaid expense and other assets changed year-over-year?
- Denali Therapeutics Inc.'s increase (decrease) in prepaid expense and other assets decreased by 92.0% year-over-year, from $28.61M to $2.29M.
- What does increase (decrease) in prepaid expense and other assets mean?
- This tracks changes in cash paid in advance for goods or services that will be consumed in future periods. It reflects the timing difference between cash outflows and the recognition of related expenses on the income statement.